** Shares of Recce Pharmaceuticals RCE.AX fall 7.7% to A$0.300, their lowest levels since April 2, 2020
** The pharmaceutical co announces a placement of A$5 million ($3.06 million) and an entitlement offer of A$10.8 million to fund clinical trials in Indonesia and Australia
** Issue price of A$0.28 for the placement represents a 13.8% discount to co's last close
** Stock down ~38% YTD, including current session's moves
($1 = 1.6332 Australian dollars)
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。